SCHEMBL8589979

SCHEMBL8589979

CC(C)(C)C(=O)N1CCCC(c2ccc(Cl)c(Cl)c2)C1CCN1CCC(Cc2ccccc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 8/20 0.45
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RIPK1 Q13546 1/20 0.43
OPRK1 P41145 3/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
TACR1 P25103 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTR2B P41595 1/20 0.40
MAPK14 Q16539 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8593273 0.87 UTS2R (0.56) UTS2RKDM4EMEN1ALDH1A1KMT2A
SCHEMBL8594648 0.84 TACR1 (0.42) UTS2RMEN1KMT2ASMN1; SMN2RIPK1
SCHEMBL8589975 0.83 RIPK1 (0.41) UTS2RKDM4EMEN1ALDH1A1KMT2A
SCHEMBL8592265 0.81 UTS2R (0.50) UTS2RKDM4EMEN1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL8591692 0.75 HTR1A (0.49) OPRK1SLC6A4
SCHEMBL8590156 0.74 SLC6A2 (0.45) KDM4EMEN1ALDH1A1KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL8591080 0.73 SLC6A2 (0.44) KDM4EALDH1A1SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL8593270 0.72 UTS2R (0.47) UTS2ROPRK1TACR1CYP2C9CYP2C19
SCHEMBL8589466 0.71 TACR1 (0.46) UTS2ROPRK1CYP3A4CYP2D6TACR1
SCHEMBL8590158 0.71 SLC6A2 (0.53) KDM4EMEN1ALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5770735-A Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present ELF SANOFI (FR) 1998-06-23 US disclosed